TelyRx Holdings Inc. shares surged by over 17% in the latest trading session, reflecting strong investor interest.
In a remarkable turn of events, TelyRx Holdings Inc. (TELY.TO) saw its stock price jump by 17.39% in yesterday's trading session, closing at CA$2.70. This surge comes amidst increasing revenues and strategic corporate developments that have caught investors' attention.
Advertisement
Get up to $2,000 cash back
Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.
TelyRx Holdings Inc.
TELY.TO
TELY.TO
TelyRx Holdings Inc.
WealthAwesomeMarket cap
$66.45M
52W high
$4.25
52W low
$2.00
1W change
+2.94%
Analyst Price Targets
Based on analyst covering TELY
Wall Street analysts forecast TELY stock price to rise 144.9% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$6.00
+144.9% Upside
Current Price
C$2.45
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on TELY's historical volatility
30-Day Vol
83.1%
Annualized
90-Day Vol
92.4%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$2.05
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$2.31 | C$1.73 โ C$3.07 |
| 60 trading days | C$2.18 | C$1.45 โ C$3.26 |
| 90 trading days | C$2.05 | C$1.25 โ C$3.37 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors should consider the potential for growth in TelyRx Holdings, especially given its recent financial performance and market positioning.
TelyRx Holdings Inc. Sees 17.39% Surge in Stock Price
The stock's impressive rise reflects growing investor confidence in TelyRx's business model and future prospects.
Bull case
TelyRx's recent financial results show a significant revenue increase, indicating that the company is on a growth path. This could attract investors looking for opportunities in the healthcare sector.
Bear case
Despite the positive movement, TelyRx still faces challenges, including a net loss reported in its latest financial results. This may raise concerns about its profitability in the near term.
Financial Performance Highlights
TelyRx reported a remarkable revenue increase to CA$19.4 million for Q1 2026, up from CA$6.9 million in the same quarter last year. This growth highlights the company's potential in the healthcare sector, despite a net loss of CA$4.7 million.
Market Reaction and Investor Sentiment
The stock's surge reflects a positive market reaction to TelyRx's recent developments, including its name change and trading commencement on the TSX. Investors are showing increased interest, likely driven by the company's growth narrative.
Looking Ahead
As TelyRx continues to navigate its growth path, investors should keep an eye on upcoming financial results and market strategies. For more insights on TelyRx Holdings Inc., visit our stock page for detailed analysis and updates.
Advertisement
